Oruka Therapeutics, Inc. ORKA Exchange Of Series A Convertible Preferred Stock For Series B Nonvoting Convertible Preferred Stock Upon The Closing Of The Reverse Capitalization
Exchange Of Series A Convertible Preferred Stock For Series B Nonvoting Convertible Preferred Stock Upon The Closing Of The Reverse Capitalization at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept orka:ExchangeOfSeriesAConvertiblePreferredStockForSeriesBNonvotingConvertiblePreferredStockUponTheClosingOfTheReverseCapitalization.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s exchange of series a convertible preferred stock for series b nonvoting convertible preferred stock upon the closing of the reverse capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s exchange of series a convertible preferred stock for series b nonvoting convertible preferred stock upon the closing of the reverse capitalization?
- Oruka Therapeutics, Inc. (ORKA) reported exchange of series a convertible preferred stock for series b nonvoting convertible preferred stock upon the closing of the reverse capitalization of $2.93M in Q4 2024.
- What does exchange of series a convertible preferred stock for series b nonvoting convertible preferred stock upon the closing of the reverse capitalization mean?
- Reflects the non-cash conversion or exchange of specific classes of preferred equity instruments into other forms of capital. This metric is used to track changes in the company's capital structure resulting from corporate restructuring or financing agreements.